COOLTERM 104 FRAMING ERROR SERIAL
COOLTERM 104 FRAMING ERROR MANUAL

Reading after this sequence should work correctly.

Your block diagram should appear as shown below:ī. You may be closing the VISA Resource before the Read/Write task is complete.Ĭ.

COOLTERM 104 FRAMING ERROR SERIAL

Your serial port and device may be configured to use different settings.

To solve this issue, open NI Measurement & Automation Explorer (NI MAX) and select your serial port under Devices and Interfaces. Verify that the VISA Resource Name, Baud rate, Data bits, Parity, and Stop bits all match the settings of your device under the port settings tab. The easiest way to check the configuration is by tracing the received signal with an oscilloscope. Note: You can change these settings programmatically during run-time as seen in the example above, or in NI-MAX as in the example below.ĭ. Check to make sure your cables are securely plugged in.Į. You may have a bad serial cable or the wrong type of serial cable.

COOLTERM 104 FRAMING ERROR MANUAL

Try another serial cable and check your device manual to determine if a null modem or straight through cable is required. Refer to the article: Should I Use Null Modem or Straight Through Serial Cables?į. You may be experiencing noise on your serial line. Move the serial cable way from power cables, monitors, or other potential noise sources. This is unlikely, but to use serial devices you need to have LabVIEW, NI-Serial, and NI-VISA on your computer. You may need to repair these installations if the error continues and you have tried all of the steps above.Over those six years, Ross’ lab has been looking at unconventional structures for and publishing about multifunctional inhibitors. But when it came to this drug, a PI3K and MAPK inhibitor dubbed LP-182, they noticed it was behaving differently and that it was being absorbed at a different rate. “After talking to colleagues, we thought perhaps this is a lymphatically absorbed drug. “It was quite astonishing, actually.” So we retooled the group, retooled the lab … and we found it, in fact, was lymphatically absorbed,” Ross said. “To my mind, it’s the world’s first kinase inhibitor that’s lymphatically absorbed,” he said.

Most oral drugs are absorbed through the blood, meaning they first pass through the liver, where some drugs are metabolized. The broken-down parts of those drugs can contribute to liver damage, but their drug avoided that by going through the lymph system, according to Ross. Instead, the lymph nodes were “sort of like a gas can that you fill up in your car,” Ross said. “The drug is filling up this big reservoir - it’s being sequestered away from the entire body by the absorption, and then slowly draining over a day into a neck vein.”Īnd that slow drip from the lymphatic system means that the drug doesn’t cause an initial spike like traditional oral drugs. When the researchers put the drug into mice with myelofibrosis, a form of blood cancer where scar tissue builds up in the bone marrow, they saw that all the mice treated with their drug survived to 28 days after treatment - the planned cutoff for the study - while control group mice had progressive disease, “reaching humane endpoints” before 21 days. The catch, however, is that Ross and his team are still figuring out how exactly their drug works.

Coolterm 104 framing error